In consistent, we found INSL5 expression was mainly detected in cancer cells rather than in stromal cells or normal epithelial cells in 18 NPC tumor samples by immunohistochemistry (Fig EV1D). The gene discussed is INSL5; the disease is nasopharyngeal carcinoma.